官方服务：
资源简介：
A csv file containing the nucleotide counts for each position of gDNA 10^-3 sample, replicate 2.
应用场景：
创建时间：
2019-01-01
相关数据集
Therascreen KRAS RGQ PCR Kit
An interventional, prospective IVD device study for the testing of DNA extracted from tumor tissue biopsy samples from patients with Colorectal Cancer (CRC) who have previously tested positive for the
NIAID Data Ecosystem60
Performance and Cost Efficiency of KRAS Mutation Testing for Metastatic Colorectal Cancer in Routine Diagnosis: The MOKAECM Study, a Nationwide Experience
Purpose Rapid advances in the understanding of cancer biology have transformed drug development thus leading to the approval of targeted therapies and to the development of molecular tests to select p
NIAID Data Ecosystem30
Supplementary table 1. The target value range of each mutant of the quality control. Supplementary table 2. The judging rule of the KRAS mutant gene. Supplementary table 3. Detection of the mutKRAS ctDNA in all enrolled patients.
Supplementary table 1. The target value range of each mutant of the quality controlSupplementary table 2. The judging rule of the KRAS mutant gene.Supplementary table 3. Detection of the mutKRAS ctDNA
DataCite Commons2024-05-17 更新30
Number of NSCLC samples in agreement between ARMS kit and MALDI-TOF in assays common to both kits.
aFigure does not include samples where they failed KRAS ARMS analysis.
NIAID Data Ecosystem50
Method characteristics of dideoxy-sequencing, DxS-KRAS and KRAS-TMGB in diagnostic KRAS mutation assessment (KRAS codons 12 and 13).
* = results may not be accurate in cases with tumor cell content below the selectivity of this method, even in samples with preserved DNA & = reported by the manufacturer ˆ = failure to obtain re
NIAID Data Ecosystem30
